Anesthesia Effect and Safety Study of Ciprofol Combined with Low-Dose Sufentanil in Fiberoptic Bronchoscopy

Anesthetic effect and safety of ciprofol combined with low dose sufentanil in fiberoptic bronchoscopy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069791

Enrollment

Unknown

Registered

2023-03-26

Start date

2023-03-26

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchoscopy for related diseases

Interventions

Ciprofol group:Ciprofol 0.4mg/kg was used for induction of anesthesia

control group:2mg/kg propofol was used for induction of anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Pulmonary shadow was diagnosed; ? Painless bronchoscopy should be performed at selected time; ? Age 18-70 years old; ?ASA classification ?-?; ?BMI18-28kg/m2; ? No bronchoscopy contraindications

Exclusion criteria

Exclusion criteria: ? Patients with severe organ dysfunction such as heart, liver and kidney; ? Patients with a history of chronic pain and long-term use of opioids; (3) Patients with central nervous system diseases, speech, hearing and mental disorders; ? difficult airway; (5) Allergic to the study drug; ? Check time >1h; ? Patients considered unsuitable for clinical study by researchers

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;oxygen saturation;	—

Secondary

Measure	Time frame
induction time;Incidence of injection pain;recovery time;Adverse event rates;	—

Countries

China

Contacts

Public ContactLiu Wei

Beijing Chest Hospital, Capital Medical University

lw1200@sina.com13621153330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026